NPR counted over 1,000 FDA reports of optic neuropathy tied to GLP-1s since 2024. Novo Nordisk calls the claims meritless and Lilly says it will fight them.
Recap by typeshit. Full story at NPR.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
A Facebook post says rapid weight loss on these drugs can raise gallstone risk, and lists warning signs like severe upper belly pain, fever and yellow eyes.
TheStreet looks at what that means for patients paying up to $1,500 a month for peptide therapy and how the ruling could affect what they pay.
Loading…